Peptonic Medical

Executive Summary

Peptonic Medical is a Swedish biotech company specializing in scientifically proven, OTC self-care products for intimate women's health, including vaginal atrophy. Its brands VagiVital and Vernivia, along with white-label partnerships, target a large addressable market of women seeking non-prescription solutions. The company operates in the Nordics, USA, and parts of Europe, leveraging its patent-protected technology. While privately held and lacking disclosed funding or valuation, Peptonic Medical has a commercial track record and potential for growth through geographic expansion and new product launches. Key risks include competition from established players and regulatory hurdles in new markets.

Upcoming Catalysts (preview)

• Q3 2026US market expansion via new distribution partnerships60% success
• TBDNew product launch addressing women's health (e.g., moisturizer or lubricant)70% success
• Q4 2026Positive results from post-market clinical study on VagiVital50% success